These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 32743846

  • 1. Cytoprotective autophagy induction by withaferin A in prostate cancer cells involves GABARAPL1.
    Hahm ER, Singh SV.
    Mol Carcinog; 2020 Oct; 59(10):1105-1115. PubMed ID: 32743846
    [Abstract] [Full Text] [Related]

  • 2. RNA-seq reveals novel mechanistic targets of withaferin A in prostate cancer cells.
    Kim SH, Hahm ER, Singh KB, Shiva S, Stewart-Ornstein J, Singh SV.
    Carcinogenesis; 2020 Jul 10; 41(6):778-789. PubMed ID: 32002539
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Withaferin A Induces Cell Death Selectively in Androgen-Independent Prostate Cancer Cells but Not in Normal Fibroblast Cells.
    Nishikawa Y, Okuzaki D, Fukushima K, Mukai S, Ohno S, Ozaki Y, Yabuta N, Nojima H.
    PLoS One; 2015 Jul 10; 10(7):e0134137. PubMed ID: 26230090
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. PAWR-mediated suppression of BCL2 promotes switching of 3-azido withaferin A (3-AWA)-induced autophagy to apoptosis in prostate cancer cells.
    Rah B, ur Rasool R, Nayak D, Yousuf SK, Mukherjee D, Kumar LD, Goswami A.
    Autophagy; 2015 Jul 10; 11(2):314-31. PubMed ID: 25803782
    [Abstract] [Full Text] [Related]

  • 8. Honokiol activates reactive oxygen species-mediated cytoprotective autophagy in human prostate cancer cells.
    Hahm ER, Sakao K, Singh SV.
    Prostate; 2014 Sep 10; 74(12):1209-21. PubMed ID: 25043291
    [Abstract] [Full Text] [Related]

  • 9. Autophagy fails to alter withaferin A-mediated lethality in human breast cancer cells.
    Hahm ER, Singh SV.
    Curr Cancer Drug Targets; 2013 Jul 10; 13(6):640-50. PubMed ID: 23607597
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Proteomic characterization of Withaferin A-targeted protein networks for the treatment of monoclonal myeloma gammopathies.
    Dom M, Offner F, Vanden Berghe W, Van Ostade X.
    J Proteomics; 2018 May 15; 179():17-29. PubMed ID: 29448055
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells.
    Szarc vel Szic K, Op de Beeck K, Ratman D, Wouters A, Beck IM, Declerck K, Heyninck K, Fransen E, Bracke M, De Bosscher K, Lardon F, Van Camp G, Vanden Berghe W.
    PLoS One; 2014 May 15; 9(2):e87850. PubMed ID: 24498382
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. GABARAPL1 suppresses metastasis by counteracting PI3K/Akt pathway in prostate cancer.
    Su W, Li S, Chen X, Yin L, Ma P, Ma Y, Su B.
    Oncotarget; 2017 Jan 17; 8(3):4449-4459. PubMed ID: 27966458
    [Abstract] [Full Text] [Related]

  • 16. The Role of Forkhead Box Q1 Transcription Factor in Anticancer Effects of Withaferin A in Breast Cancer.
    Kim SH, Singh KB, Hahm ER, Singh SV.
    Cancer Prev Res (Phila); 2021 Apr 17; 14(4):421-432. PubMed ID: 33509807
    [Abstract] [Full Text] [Related]

  • 17. Autophagy is differentially induced in prostate cancer LNCaP, DU145 and PC-3 cells via distinct splicing profiles of ATG5.
    Ouyang DY, Xu LH, He XH, Zhang YT, Zeng LH, Cai JY, Ren S.
    Autophagy; 2013 Jan 17; 9(1):20-32. PubMed ID: 23075929
    [Abstract] [Full Text] [Related]

  • 18. Disease Subtype-Independent Biomarkers of Breast Cancer Chemoprevention by the Ayurvedic Medicine Phytochemical Withaferin A.
    Samanta SK, Sehrawat A, Kim SH, Hahm ER, Shuai Y, Roy R, Pore SK, Singh KB, Christner SM, Beumer JH, Davidson NE, Singh SV.
    J Natl Cancer Inst; 2017 Jun 17; 109(6):. PubMed ID: 28040797
    [Abstract] [Full Text] [Related]

  • 19. Withaferin A inhibits expression of ataxia telangiectasia and Rad3-related kinase and enhances sensitivity of human breast cancer cells to cisplatin.
    Hahm ER, Lee J, Abella T, Singh SV.
    Mol Carcinog; 2019 Nov 17; 58(11):2139-2148. PubMed ID: 31441116
    [Abstract] [Full Text] [Related]

  • 20. Withaferin A suppresses the growth of myelodysplasia and leukemia cell lines by inhibiting cell cycle progression.
    Okamoto S, Tsujioka T, Suemori S, Kida J, Kondo T, Tohyama Y, Tohyama K.
    Cancer Sci; 2016 Sep 17; 107(9):1302-14. PubMed ID: 27311589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.